Michael Scharl

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Topics

Chronic Rhinosinusitis

Top Venues

Therapeutic advances in gastroenterology

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Emilie Gueguen, Yasser Morsy, Céline Mamie, Alain Schoepfer, Catherine Saner, Luc Biedermann, Alex Straumann, Andrea Kreienbühl, null null, Michael Scharl, Marcin Wawrzyniak
Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis. Gut 73 (7) (2024)
Emilie Gueguen, Yasser Morsy, Céline Mamie, Alain Schoepfer, Catherine Saner, Luc Biedermann, Alex Straumann, Andrea Kreienbühl, null null, Michael Scharl, Marcin Wawrzyniak
Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis. Gut (2024)
Emilie Gueguen, Yasser Morsy, Céline Mamie, Alain Schoepfer, Catherine Saner, Luc Biedermann, Alex Straumann, Andrea Kreienbühl, null null, Michael Scharl, Marcin Wawrzyniak
Novel transcriptomic panel identifies histologically active oesinophilic oesophagitis. Gut (2024)
Emilie Gueguen, Yasser Morsy, Céline Mamie, Alain Schoepfer, Catherine Saner, Luc Biedermann, Alex Straumann, Andrea Kreienbühl, null null, Michael Scharl, Marcin Wawrzyniak
Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis. Gut 73 (7) (2024)
Emilie Gueguen, Yasser Morsy, Céline Mamie, Alain Schoepfer, Catherine Saner, Luc Biedermann, Alex Straumann, Andrea Kreienbühl, null null, Michael Scharl, Marcin Wawrzyniak
Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis. Gut (2024)
Emilie Gueguen, Yasser Morsy, Céline Mamie, Alain Schoepfer, Catherine Saner, Luc Biedermann, Alex Straumann, Andrea Kreienbühl, null null, Michael Scharl, Marcin Wawrzyniak
Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis. Gut 73 (7) (2024)
Emilie Gueguen, Yasser Morsy, Céline Mamie, Alain Schoepfer, Catherine Saner, Luc Biedermann, Alex Straumann, Andrea Kreienbühl, null null, Michael Scharl, Marcin Wawrzyniak
Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis. Gut 73 (7) (2024)
Barbara E Stähli, Michael Scharl, Christian M Matter
A roadmap for gut microbiome-derived aromatic amino acids for improved cardiovascular risk stratification. European heart journal (2023)
Robin John Dart, Pierre Ellul, Michael Scharl, Christopher Andrew Lamb
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD - Challenges and Future Directions. Journal of Crohn's & colitis 15 (9) (2022)
Marlene Schwarzfischer, Anna Niechcial, Kristina Handler, Yasser Morsy, Marcin Wawrzyniak, Andrea S Laimbacher, Kirstin Atrott, Roberto Manzini, Katharina Baebler, Larissa Hering, Egle Katkeviciutė, Janine Häfliger, Silvia Lang, Maja E Keller, Jérôme Woodtli, Lisa Eisenbeiss, Thomas Kraemer, Elisabeth M Schraner, Mahesa Wiesendanger, Sebastian Zeissig, Gerhard Rogler, Andreas E Moor, Michael Scharl, Marianne Rebecca Spalinger
TiO 2 nanoparticles abrogate the protective effect of the Crohn's disease-associated variation within the PTPN22 gene locus. Gut (2022)
Zsófia Agnes Bittner, Xiao Liu, Maria Mateo Tortola, Ana Tapia-Abellán, Sangeetha Shankar, Liudmila Andreeva, Matthew S J Mangan, Marianne Rebecca Spalinger, Hubert Kalbacher, Peter Duewell, Marta Lovotti, Karlotta Bosch, Sabine Dickhöfer, Ana Marcu, Stefan Stevanovic, Franziska Herster, Yamel Cardona Gloria, Tzu-Hsuan Chang, Francesca Bork, Carsten L Greve, Markus W Löffler, Olaf-Oliver Wolz, Nadine A Schilling, Jasmin Beate Kuemmerle-Deschner, Samuel Wagner, Anita Delor, Bodo Grimbacher, Oliver Hantschel, Michael Scharl, Hao Wu, Eicke Latz, Alexander N R Weber
BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity. The Journal of experimental medicine 218 (11) (2021)
Bernhard Morell, Philipp Karl Buehler, Patrick Raphael Bader, Silvia Lang, Michael Scharl, Christoph Gubler, Fritz Ruprecht Murray
Efficient treatment of esophageal nutrition bezoars: dissolution outmatches removal-the Zurich approach. Clinical journal of gastroenterology 14 (6) (2021)
Salomon M Manz, Marco Losa, Ralph Fritsch, Michael Scharl
Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer. Therapeutic advances in gastroenterology 14 (2021)
Marianne Rebecca Spalinger, Ali Shawki, Pritha Chatterjee, Vinicius Canale, Alina Santos, Anica Sayoc-Becerra, Michael Scharl, Michel L Tremblay, James Borneman, Declan F McCole
Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence. Gut 71 (1) (2021)
Lorenz Grob, Sena Blümel, Luc Biedermann, Nicolas Fournier, Jean-Benoit Rossel, Stephan R Vavricka, Jonas Zeitz, Gerhard Rogler, Andreas Stallmach, Michael Scharl
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study. Therapeutic advances in gastroenterology 13 (2020)
Marianne R Spalinger, Rong Hai, Jiang Li, Alina N Santos, Tara M Nordgren, Michel L Tremblay, Lars Eckmann, Elaine Hanson, Michael Scharl, Xiwei Wu, Brigid S Boland, Declan F McCole
Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells. bioRxiv : the preprint server for biology (2020)
Felicitas Ditrich, Sena Blümel, Alex Straumann, Nicolas Fournier, Jean-Benoit Rossel, David Ellinghaus, Andre Franke, Eduard F Stange, Gerhard Rogler, Michael Scharl, null null
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohort. Therapeutic advances in gastroenterology 13 (2020)
Philipp Schreiner, Jean-Benoît Rossel, Luc Biedermann, Philipp O Valko, Christian R Baumann, Thomas Greuter, Michael Scharl, Stephan R Vavricka, Valérie Pittet, Pascal Juillerat, Gerhard Rogler, Roland von Känel, Benjamin Misselwitz, null null
Fatigue in inflammatory bowel disease and its impact on daily activities. Alimentary pharmacology & therapeutics 53 (1) (2020)
Susan Bengs, Eugenia Becker, Philipp Busenhart, Marianne R Spalinger, Tina Raselli, Stephanie Kasper, Silvia Lang, Kirstin Atrott, Celine Mamie, Stephan R Vavricka, Lotta von Boehmer, Alexander Knuth, Anne Tuomisto, Markus J Mäkinen, Petr Hruz, Matthias Turina, Andreas Rickenbacher, Henrik Petrowsky, Achim Weber, Pascal Frei, Marcel Halama, Gisli Jenkins, Dean Sheppard, Roland S Croner, Jan Christoph, Nathalie Britzen-Laurent, Elisabeth Naschberger, Vera Schellerer, Michael Stürzl, Michael Fried, Gerhard Rogler, Michael Scharl
β6 -integrin serves as a novel serum tumor marker for colorectal carcinoma. International journal of cancer 145 (3) (2019)
Nina Roth, Luc Biedermann, Nicolas Fournier, Matthias Butter, Stephan R Vavricka, Alexander A Navarini, Gerhard Rogler, Michael Scharl, null null
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study. PloS one 14 (1) (2019)
Luc Biedermann, Laura Renz, Nicolas Fournier, Jean-Benoît Rossel, Matthias Butter, Sena Bluemel, Stephan R Vavricka, Gerhard Rogler, Michael Scharl
Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study. Therapeutic advances in gastroenterology 12 (2019)
Aimee Hiller, Luc Biedermann, Nicolas Fournier, Matthias Butter, Stephan R Vavricka, Adrian Ciurea, Gerhard Rogler, Michael Scharl, null null
The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort. PloS one 14 (4) (2019)
Bahtiyar Yilmaz, Marianne R Spalinger, Luc Biedermann, Yannick Franc, Nicolas Fournier, Jean-Benoit Rossel, Pascal Juillerat, Gerhard Rogler, Andrew J Macpherson, Michael Scharl
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients. PloS one 13 (7) (2018)